References
- Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension 2003;41:437–45
- Sibai B, Dekker G, Kupferminc M. Preeclampsia. Lancet 2005;365:785–99
- Gilbert CS, Gilbert SA, Arany M, Granger JP. Placental ischemia and cardiovascular dysfunction in preeclampsia and beyond: making the connections. Hypertension 2009;53:399–403
- Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 1997;37:240–9
- Hall DR, Odendaal HJ, Kirsten GF, et al. Expectant management of early onset, severe pre-eclampsia: perinatal outcome. BJOG 2000;107:1258–64
- Masuyama H, Segawa T, Sumida Y, et al. Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset pre-eclampsia. BJOG 2010;117:314–20
- Escudero C, Sobrevia L. A hypothesis for preeclampsia: adenosine and inducible nitric oxide synthase in human placental microvascular endothelium. Placenta 2008;29:469–83
- Rajakumar RA, Whitelock KA, Daftary AR, et al. Overexpression of the hypoxia-inducible transcription factors HIF-1α and HIF-2α, in placentas from women with preeclampsia. Biol Reprod 2001;64:499–506
- Gigante B, Morlino G, Gentile MT, et al. Plgf-/-eNos-/- mice show defective angiogenesis associated with increased oxidative stress in response to tissue ischemia. FASEB J 2006;20:970–2
- Tranquilli AL, Bezzeccheri V, Giannubilo SR, et al. Amniotic vascular endothelial growth factor (VEGF) and nitric oxide (NO) in women with subsequent preeclampsia. Eur J Obstet Gynecol Reprod Biol 2004;113:17–20
- Myatt L, Webster RP. Vascular biology of preeclampsia. J Thromb Haemost 2009;7:375–84
- Cortas NK, Wakid NW. Determination of inorganic nitrate in serum andurine by kinetic cadmium-reduction method. Clin Chem 1990;36:1440–3
- Zamudio S, Wu Y, Ietta F, et al. Human placental hypoxia-inducible factor-1alpha expression correlates with clinical outcomes in chronic hypoxia in vivo. Am J Pathol 2007;170:2171–9
- Rajakumar A, Doty K, Daftary A, et al. Impaired oxygen-dependent reduction of HIF-1alpha and -2alpha proteins in pre-eclamptic placentae. Placenta 2003;24:199–208
- Rajakumar A, Brandon HM, Daftary A, et al. Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae. Placenta 2004;25:763–9
- Sezer SD, Küçük M, Döger FK, et al. VEGF, PIGF and HIF-1α in placentas of early- and late-onset pre-eclamptic patients. Gynecol Endocrinol 2013;29:797–800
- Thangaratinam S, Langenveld J, Mol BW, Khan KS. Prediction and primary prevention of pre-eclampsia. Best Pract Res Clin Obstet Gynaecol 2011;25:419–33
- Lyall F, Young A, Greer IA. Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. Am J Obstet Gynecol 1995;173:714–18
- Sandrim VC, Palei AC, Metzger IF, et al. Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia. Hypertension 2008;52:402–7
- Salama RH, Fathalla MM, Mekki AR, Elsadek Bel-K. Implication of umbilical cord in preeclampsia. Med Princ Pract 2011;20:124–8
- Di Iorio R, Marinoni E, Emiliani S, et al. Nitric oxide in preeclampsia: lack of evidence for decreased production. Eur J Obstet Gynecol Reprod Biol 1998;76:65–70
- Myatt L, Eis AL, Brockman DE, et al. Endothelial nitric oxide synthase in placental villous tissue from normal, preeclamptic and intrauterine growth restricted pregnancies. Hum Reprod 1997;12:167–72
- Sezer SD, Küçük M, Yüksel H. Angiogenic and anti-angiogenic factors in the etiology of pre-eclampsia: review. Turkiye Klinikleri J Gynecol Obst 2012;22:42–7